StemCell Therapy

ISELIN, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment of retinal diseases in the US and the EU, today announced that it has closed its previously announced private placement with Syntone Ventures, LLC, an existing stockholder, for upfront gross proceeds of approximately $5.0 million from the issuance and sale of shares of the Company’s common stock and accompanying warrants, before deducting offering expenses. In addition, Outlook Therapeutics has the potential to receive additional gross proceeds of up to $8 million upon the full cash exercise of the warrants issued in the private placement, before deducting offering expenses.

Read this article:
Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million

Scientists Find Key To Potential Breast Cancer Prevention, Treatment | Newsroom  UNC Health and UNC School of Medicine

Go here to see the original:
Scientists Find Key To Potential Breast Cancer Prevention, Treatment | Newsroom - UNC Health and UNC School of Medicine

The Integrative Medicine Service provides evidence-based complementary therapies to improve our patients experiences, physical outcomes, emotional wellness, and quality of life.

Our diverse multidisciplinary team includes medicine, acupuncture, massage therapy, creative arts therapies, mind-body therapies, and exercise. We offer a patient-centered approach that evaluates and helps people manage the emotional burden of their diagnosis and complications that arise from cancer treatment.

Our team of experts provides nurturing therapies that address chronic issues such as pain, neuropathy, fatigue and insomnia, stress, anxiety, mobility, and more.

Since 1999, our Integrative Medicine Service has been leading the field in innovative, patient-centered research. Our doctors and researchers studying how integrative therapies can be used to better control or reduce the side effects of cancer treatment.

Through activities like fellowships, onsite training programs, online courses, and our award-winning About Herbs library, we teach and train health care providers about best clinical practices, and the value of integrative medicine in cancer care.

About HerbsExplore MSKs award-winning About Herbs online library and mobile app for objective information on the potential benefits and risks of using dietary supplements and herbal products.

Continuing Education& TrainingOur online continuing education courses and onsite training opportunities prepare doctors, acupuncturists, nurses, and integrative health specialists to practice evidence-based integrative cancer care in their local community. MSK faculty members design every program with your needs and those of people with cancer everywhere in mind.

Refer a PatientFind out how to refer a patient to MSKs team of integrative medicine doctors and therapists, who provide a spectrum of care to people with cancer.

Research & Clinical TrialsDiscover how MSK helps move the field of integrative oncology forward through high-quality studies, many of which are open at any given time.

More here:
Integrative Medicine Service - Memorial Sloan Kettering Cancer Center

Understanding the Dynamics of Innate Immune System in SARS-CoV-2 Infection and Its Potential for Treatment  Medriva

Here is the original post:
Understanding the Dynamics of Innate Immune System in SARS-CoV-2 Infection and Its Potential for Treatment - Medriva